Related references
Note: Only part of the references are listed.New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation
Anna Tashchilova et al.
MOLECULES (2022)
Inhibiting factor XIa to prevent thromboembolism
Gregory B. Lim
NATURE REVIEWS CARDIOLOGY (2022)
Supercomputer Search for the New Inhibitors of the Coagulation Factor XIIa
A. Sulimov et al.
LOBACHEVSKII JOURNAL OF MATHEMATICS (2022)
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa
Nadezhda Novichikhina et al.
MOLECULES (2020)
Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action
Marvin Korff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling
Ivan Ilin et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2019)
Identifying novel factor XIIa inhibitors with PCA-GA-SVM developed vHTS models
Jonathan Jun Feng Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery and assessment of water soluble coumarins as inhibitors of the coagulation contact pathway
Charlotte Bouckaert et al.
THROMBOSIS RESEARCH (2017)
Factor XII inhibition reduces thrombus formation in a primate thrombosis model
Anton Matafonov et al.
BLOOD (2014)
A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk
Magnus Larsson et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Application of the Docking Program SOL for CSAR Benchmark
Alexey V. Sulimov et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Development of a Selective Peptide Macrocycle Inhibitor of Coagulation Factor XII toward the Generation of a Safe Antithrombotic Therapy
Vanessa Baeriswyl et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters
James J. P. Stewart
JOURNAL OF MOLECULAR MODELING (2013)
Factor XI and XII as antithrombotic targets
Felicitas Mueller et al.
CURRENT OPINION IN HEMATOLOGY (2011)
Arterial thrombosis-insidious, unpredictable and deadly
Shaun P. Jackson
NATURE MEDICINE (2011)
Inhibition of Factor XIa as a New Approach to Anticoagulation
William A. Schumacher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Factor XIIa Inhibitor Recombinant Human Albumin Infestin-4 Abolishes Occlusive Arterial Thrombus Formation Without Affecting Bleeding
Ina Hagedorn et al.
CIRCULATION (2010)
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
Felicitas Muller et al.
CELL (2009)
Contributions of contact activation pathways of coagulation factor XII in plasma
Kaushik Chatterjee et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2009)
Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors
Severine Robert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Highly potent and selective substrate analogue factor Xa inhibitors containing D-homophenylalanine analogues as P3 residue:: Part 2
Anne Stuerzebecher et al.
CHEMMEDCHEM (2007)
The intrinsic pathway of coagulation:: a target for treating thromboembolic disease?
D. Gailani et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Share Paper
